Myelodysplastic Syndrome Clinical Trial

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Summary

This is a study to collect the outcomes of stem cell transplantation for patients with hematologic diseases other than cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of Sickle Cell Disease, Thalassemia, Diamond Blackfan Anemia or other non-malignant hematologic disorders for which a stem cell transplant is indicated
Acceptable stem cell source identified
Performance status of ≥ 70% (Karnofsky),or ≥ 70 (Lansky play score)
Creatinine <2.0 mg/dl for adults or glomerular filtration rate > 50 ml/min for children
Bilirubin, Aspartate Aminotransferase, Alkaline phosphatase <5 times the upper limit of institutional normal
Absence of decompensated congestive heart failure, or uncontrolled arrhythmia and left ventricular ejection fraction > 40%

Exclusion Criteria:

active, uncontrolled infection
pregnant or breastfeeding
HIV positive

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

25

Study ID:

NCT02179359

Recruitment Status:

Recruiting

Sponsor:

Masonic Cancer Center, University of Minnesota

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Minnesota Medical Center, Fairview
Minneapolis Minnesota, 55455, United States More Info
Lisa Burke
Contact
612-273-8482
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

25

Study ID:

NCT02179359

Recruitment Status:

Recruiting

Sponsor:


Masonic Cancer Center, University of Minnesota

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.